Journal
DRUG DISCOVERY TODAY
Volume 19, Issue 2, Pages 126-132Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2013.06.003
Keywords
-
Categories
Funding
- Spanish Ministry of Science and Innovation [BIO2011-27069]
- GVA-FEDER [PROMETEO/2010/001]
Ask authors/readers for more resources
The popularization of genomic high-throughput technologies is causing a revolution in biomedical research and, particularly, is transforming the field of drug discovery. Systems biology offers a framework to understand the extensive human genetic heterogeneity revealed by genomic sequencing in the context of the network of functional, regulatory and physical protein-drug interactions. Thus, approaches to find biomarkers and therapeutic targets will have to take into account the complex system nature of the relationships of the proteins with the disease. Pharmaceutical companies will have to reorient their drug discovery strategies considering the human genetic heterogeneity. Consequently, modeling and computational data analysis will have an increasingly important role in drug discovery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available